Study of 17-Oxosteroid Excretion in Women with Breast Cancer After Hypophysectomy
Author Information
Author(s): A. A. Khattab, D. N. Baron
Primary Institution: Department of Chemical Pathology, The Royal Free Hospital
Hypothesis
Does hypophysectomy affect the excretion of 17-oxosteroids in women with breast cancer?
Conclusion
After complete hypophysectomy, dehydroepiandrosterone was not found in urine, but androsterone and aetiocholanolone continued to be excreted.
Supporting Evidence
- 17-oxosteroid excretion was low before hypophysectomy but qualitatively normal.
- Dehydroepiandrosterone was absent in urine after complete hypophysectomy.
- Androsterone and aetiocholanolone continued to be excreted post-hypophysectomy.
Takeaway
The study looked at how a surgery called hypophysectomy affects certain hormones in women with breast cancer. It found that one hormone disappeared after the surgery, but two others were still present.
Methodology
Patients underwent hypophysectomy, and their urinary 17-oxosteroid excretion was analyzed pre- and post-surgery.
Limitations
The study faced challenges in accurately measuring 17-oxosteroid levels due to low output and interference from pigments in urine.
Participant Demographics
All patients were suffering from carcinoma of the breast, mostly post-menopausal or ovariectomized.
Want to read the original?
Access the complete publication on the publisher's website